BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8826471)

  • 1. Molecular fragile X screening in normal populations.
    Spence WC; Black SH; Fallon L; Maddalena A; Cummings E; Menapace-Drew G; Bick DP; Levinson G; Schulman JD; Howard-Peebles PN
    Am J Med Genet; 1996 Jul; 64(1):181-3. PubMed ID: 8826471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal diagnosis and carrier screening for fragile X by PCR.
    Brown WT; Nolin S; Houck G; Ding X; Glicksman A; Li SY; Stark-Houck S; Brophy P; Duncan C; Dobkin C; Jenkins E
    Am J Med Genet; 1996 Jul; 64(1):191-5. PubMed ID: 8826474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and instability of fragile X alleles: implications for offering fragile X prenatal diagnosis.
    Cronister A; Teicher J; Rohlfs EM; Donnenfeld A; Hallam S
    Obstet Gynecol; 2008 Mar; 111(3):596-601. PubMed ID: 18310361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new approach to antenatal screening for Fragile X syndrome.
    Wald NJ; Morris JK
    Prenat Diagn; 2003 Apr; 23(4):345-51. PubMed ID: 12673644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for fragile X syndrome.
    Murray J; Cuckle H; Taylor G; Hewison J
    Health Technol Assess; 1997; 1(4):i-iv, 1-71. PubMed ID: 9414543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategy for reliable prenatal detection of normal male carriers of the fragile X syndrome.
    Halley D; Van Den Ouweland A; Deelen W; Verma I; Oostra B
    Am J Med Genet; 1994 Jul; 51(4):471-3. PubMed ID: 7943022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preconceptional and prenatal screening for fragile X syndrome: experience with 40,000 tests.
    Berkenstadt M; Ries-Levavi L; Cuckle H; Peleg L; Barkai G
    Prenat Diagn; 2007 Nov; 27(11):991-4. PubMed ID: 17705235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fragile-X syndrome in east Finland: molecular approach to genetic and prenatal diagnosis.
    Ryynänen M; Pulkkinen L; Kirkinen P; Saarikoski S
    Am J Med Genet; 1994 Jul; 51(4):463-5. PubMed ID: 7943020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test.
    Brown WT; Houck GE; Jeziorowska A; Levinson FN; Ding X; Dobkin C; Zhong N; Henderson J; Brooks SS; Jenkins EC
    JAMA; 1993 Oct; 270(13):1569-75. PubMed ID: 8371467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal diagnosis in known fragile X carriers.
    Maddalena A; Hicks BD; Spence WC; Levinson G; Howard-Peebles PN
    Am J Med Genet; 1994 Jul; 51(4):490-6. PubMed ID: 7943026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Who should be tested for fragile X carriership? A review of 1 center's pedigrees.
    Rajendra K; Bringman JJ; Ward J; Phillips OP
    Am J Obstet Gynecol; 2008 May; 198(5):e51-3. PubMed ID: 18358452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic evaluation of prenatal carrier screening for fragile X syndrome.
    Vintzileos AM; Ananth CV; Fisher AJ; Smulian JC; Day-Salvatore D; Beazoglou T; Knuppel RA
    J Matern Fetal Med; 1999; 8(4):168-72. PubMed ID: 10406300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of fragile X syndrome by prenatal genetic diagnosis: advantages and controversial aspects].
    Tejada MI
    Rev Neurol; 2001 Oct; 33 Suppl 1():S14-9. PubMed ID: 12447813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility and acceptance of screening for fragile X mutations in low-risk pregnancies.
    Ryynänen M; Heinonen S; Makkonen M; Kajanoja E; Mannermaa A; Pertti K
    Eur J Hum Genet; 1999; 7(2):212-6. PubMed ID: 10196705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular diagnosis and genetic counseling for fragile X mental retardation.
    Pandey UB; Phadke SR; Mittal B
    Neurol India; 2004 Mar; 52(1):36-42. PubMed ID: 15069237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fragile X syndrome prenatal diagnosis: parental attitudes and reproductive responses.
    Xunclà M; Badenas C; Domínguez M; Rodríguez-Revenga L; Madrigal I; Jiménez L; Soler A; Borrell A; Sánchez A; Milà M
    Reprod Biomed Online; 2010 Oct; 21(4):560-5. PubMed ID: 20801083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fragile X mental retardation syndrome: from pathogenesis to diagnostic issues.
    Mandel JL; Biancalana V
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S158-65. PubMed ID: 15135801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventive screening for the fragile X syndrome.
    Turner G; Robinson H; Laing S; Purvis-Smith S
    N Engl J Med; 1986 Sep; 315(10):607-9. PubMed ID: 3736599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct mutation analysis of 495 patients for fragile X carrier status/proband diagnosis.
    Kaplan G; Kung M; McClure M; Cronister A
    Am J Med Genet; 1994 Jul; 51(4):501-2. PubMed ID: 7943028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of school children at high risk for fragile X syndrome utilizing buccal cell FMR-1 testing.
    Hagerman RJ; Wilson P; Staley LW; Lang KA; Fan T; Uhlhorn C; Jewell-Smart S; Hull C; Drisko J; Flom K
    Am J Med Genet; 1994 Jul; 51(4):474-81. PubMed ID: 7943023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.